ValuEngine Lowers Exponent (NASDAQ:EXPO) to Sell

ValuEngine lowered shares of Exponent (NASDAQ:EXPO) from a hold rating to a sell rating in a research report released on Wednesday morning, ValuEngine reports.

EXPO has been the subject of several other reports. DA Davidson initiated coverage on Exponent in a research note on Wednesday, August 28th. They issued a neutral rating for the company. Zacks Investment Research raised Exponent from a hold rating to a strong-buy rating and set a $81.00 price target for the company in a research note on Monday, September 23rd. Cantor Fitzgerald raised their price target on Exponent from $64.00 to $73.00 and gave the stock an overweight rating in a research note on Friday, July 19th. BidaskClub lowered Exponent from a buy rating to a hold rating in a research note on Thursday, September 26th. Finally, SunTrust Banks raised their price target on Exponent from $70.00 to $81.00 and gave the stock a buy rating in a research note on Friday, September 20th. One analyst has rated the stock with a sell rating, four have issued a hold rating, two have assigned a buy rating and one has given a strong buy rating to the company. The company presently has a consensus rating of Hold and an average target price of $76.75.

Shares of NASDAQ:EXPO traded up $1.31 during trading on Wednesday, hitting $70.36. The company had a trading volume of 135,800 shares, compared to its average volume of 446,743. The stock has a market cap of $3.59 billion, a price-to-earnings ratio of 56.29 and a beta of 0.41. Exponent has a one year low of $44.44 and a one year high of $72.70. The company has a fifty day simple moving average of $70.19 and a two-hundred day simple moving average of $62.04. The company has a debt-to-equity ratio of 0.05, a current ratio of 3.60 and a quick ratio of 3.60.

Exponent (NASDAQ:EXPO) last posted its quarterly earnings data on Thursday, July 18th. The business services provider reported $0.39 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.33 by $0.06. The business had revenue of $106.50 million during the quarter, compared to analyst estimates of $95.77 million. Exponent had a return on equity of 23.44% and a net margin of 19.64%. The company’s revenue for the quarter was up 11.4% on a year-over-year basis. During the same period last year, the company earned $0.34 EPS. On average, equities research analysts anticipate that Exponent will post 1.47 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which was paid on Friday, September 20th. Investors of record on Friday, September 6th were paid a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.91%. The ex-dividend date of this dividend was Thursday, September 5th. Exponent’s dividend payout ratio is currently 51.20%.

In related news, CFO Richard L. Schlenker, Jr. sold 22,243 shares of the firm’s stock in a transaction that occurred on Tuesday, August 20th. The stock was sold at an average price of $70.57, for a total transaction of $1,569,688.51. Following the completion of the sale, the chief financial officer now directly owns 247,118 shares of the company’s stock, valued at approximately $17,439,117.26. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Harri Kytomaa sold 2,000 shares of the firm’s stock in a transaction that occurred on Tuesday, August 13th. The stock was sold at an average price of $70.09, for a total value of $140,180.00. Following the sale, the insider now directly owns 9,399 shares of the company’s stock, valued at $658,775.91. The disclosure for this sale can be found here. Insiders have sold a total of 102,773 shares of company stock valued at $7,227,536 over the last three months. 2.30% of the stock is owned by corporate insiders.

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Tower Research Capital LLC TRC increased its holdings in Exponent by 787.0% during the 2nd quarter. Tower Research Capital LLC TRC now owns 612 shares of the business services provider’s stock worth $36,000 after purchasing an additional 543 shares during the period. NN Investment Partners Holdings N.V. purchased a new position in Exponent during the 2nd quarter worth $91,000. Cim LLC purchased a new position in Exponent during the 2nd quarter worth $200,000. Coldstream Capital Management Inc. purchased a new position in Exponent during the 1st quarter worth $210,000. Finally, Clarus Wealth Advisors increased its holdings in Exponent by 5.1% during the 2nd quarter. Clarus Wealth Advisors now owns 4,022 shares of the business services provider’s stock worth $235,000 after purchasing an additional 194 shares during the period. Institutional investors own 88.08% of the company’s stock.

Exponent Company Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company worldwide. Its services include analysis of product development, product recall, regulatory compliance, and the discovery of potential problems related to products, people, property, and impending litigation.

See Also: What are economic reports?

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Exponent (NASDAQ:EXPO)

Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.